Erratum to “A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting”

Abstract

Tappe W, Aggarwal S, Topaloglu O, Iacobelli, M. A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting. Clinical and Applied Thrombosis/Hemostasis. 2020;26:1-9. DOI: https://doi.org/10.1177/1076029620935202 Due to a formatting error that occurred during the layout process, the reference numbers in the published versions of Figures 2 and 3 did not align with the authors/dates shown in the figures. The correct versions of Figures 2 and 3 are below: Figure 2. Bleeding rates for IV defibrotide (A) and controls regardless of route of administration (B). CI indicates confidence interval; ES, effect size; IV, intravenous. Figure 3. Risk ratio of bleeding for IV formulation of defibrotide versus controls. bid indicates 2 times a day; CI, confidence interval; df, degrees of freedom; IV, intravenous; M-H, Mantel-Haenszel; post-op, postoperative; pre-op, preoperative; qid, 4 times a day.